Elekta
Elekta AB is a Swedish medical technology company that develops radiation therapy equipment and clinical software solutions for cancer treatment. The company operates in precision radiation therapy, stereotactic radiosurgery, and oncology informatics. Key products encompass linear accelerators, Gamma Knife radiosurgery systems, MR-guided radiation therapy systems (Elekta Unity), and oncology software solutions. Revenue is driven by capital equipment sales to healthcare facilities alongside ongoing service maintenance contracts and software licenses. Elekta maintains a leading global market position in radiosurgery and radiation oncology solutions. The company is headquartered in Stockholm, Sweden, and its shares are listed on Nasdaq Stockholm.
47 of the funds FundTelligence covers report a position in Elekta.
- Legal name
- ELEKTA AB
- Sector
- Health Care
- Country
- Sweden
- Funds holding it
- 47
Funds holding Elekta
- Lannebo Sverige Plus — Lannebo · 4.28 % (full portfolio disclosed, June 2026)
- Lannebo Sverige — Lannebo · 4.27 % (full portfolio disclosed, June 2026)
- Fidelity Nordic Fund — Fidelity · 4.2 % (largest positions only, October 2026)
- Aktiespararna Direktavkastning — Cicero Fonder · 4.14 % (full portfolio disclosed, June 2026)
- Fidelity European Value Fund — Fidelity · 3.5 % (largest positions only, October 2026)
- Aktie-Ansvar Avkastningsfond — Aktie-Ansvar · 1.79 % (full portfolio disclosed, June 2026)
- Nordea Alfa — Nordea Funds · 1.32 % (full portfolio disclosed, September 2026)
- Cicero Avkastning — Cicero Fonder · 1.3 % (full portfolio disclosed, June 2026)
Showing the 8 largest of 47 funds holding it.